---
document_datetime: 2023-09-21 17:02:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/opatanol-epar-all-authorised-presentations_en.pdf
document_name: opatanol-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7607455
conversion_datetime: 2025-12-22 11:20:35.115879
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU-number       | Invented name   | Strength   | Pharmaceutical form   | Route of administration   | Packaging     | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|---------------|---------------------------|----------------|
| EU/1/02/217/001 | Opatanol        | 1mg/ml     | Eye drops, solution   | Ocular use                | Bottle (LPDE) | 5 ml                      | 1 bottle       |
| EU/1/02/217/002 | Opatanol        | 1mg/ml     | Eye drops, solution   | Ocular use                | Bottle (LPDE) | 5 ml                      | 3 bottles      |